Evidence map›Paper›PMID 41726759›Full record

ArticleGynecologic oncology reports2026

Information needs during cancer care: qualitative research with advanced cervical cancer patients in Brazil, China, Germany, and the United States.

Elizabeth A Szamreta, Graceanne R Wayser, Vimalanand S Prabhu, Emily Mulvihill, Katherine Aguinaga, Ritu Salani

Abstract read
In one paragraph

Article in Gynecologic oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elizabeth A SzamretaMerck & Co., Inc., 126, E. Lincoln Avenue, Rahway, NJ 07065, USA.
Graceanne R WayserCerner Enviza, 2800, Rock Creek Pkwy, North Kansas City, MO 64117, USA.
Vimalanand S PrabhuMerck & Co., Inc., 126, E. Lincoln Avenue, Rahway, NJ 07065, USA.
Emily MulvihillCerner Enviza, 2800, Rock Creek Pkwy, North Kansas City, MO 64117, USA.
Katherine AguinagaCerner Enviza, 2800, Rock Creek Pkwy, North Kansas City, MO 64117, USA.
Ritu SalaniDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, 10833, Le Conte Avenue, Los Angeles, CA 90095, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Information needs for advanced cervical cancer patients have not been well studied. Our aim was to understand key drivers and barriers to seeking information, the best means of information delivery, and how this information affects the patient's treatment experience. Methods: This was a qualitative study among international cohorts to assess the information needs of adult patients diagnosed with persistent, recurrent, or metastatic cervical cancer. Semi-structured interviews were held with patients of diverse demographic and socioeconomic backgrounds within two years of obtaining their cancer diagnosis. NVivo qualitative analysis software was used to identify themes that emerged from the data. Results: In 2021, we interviewed 98 patients from Brazil (n = 25), China (n = 25), Germany (n = 20), and the United States (US) (n = 28) with a mean age ranging from 38.6 to 54.2 years. Becoming aware of treatment options and understanding prognosis were key motivators for seeking cervical cancer information. This information made patients feel more informed and confident in their care. Physicians were the preferred distributor of information due to their credibility and ability to only share information pertinent to the patient's specific stage and type of cancer. The primary challenges for seeking information were finding trustworthy resources, feeling overwhelmed with negative information, and understanding the content and relevance to their diagnosis. Conclusions: There is an unmet need for readily-found information on advanced cervical cancer that is credible, easy to understand, individualized, and stage-specific. Providing patients with this information could help them achieve a more satisfying treatment experience.

Indexed as

Advanced cervical cancerinformation needsqualitative research

Identifiers

PMID41726759
PMCPMC12923916

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.